Stockscreener 앱 받기
2.48
0.40%
0.010
시간 외 거래:
2.52
0.04
+1.61%
전일 마감가:
$2.47
열려 있는:
$2.45
하루 거래량:
10.02M
Relative Volume:
2.39
시가총액:
$384.69M
수익:
-
순이익/손실:
$-110.78M
주가수익비율:
-2.3178
EPS:
-1.07
순현금흐름:
$-75.59M
1주 성능:
+8.77%
1개월 성능:
-3.50%
6개월 성능:
-40.24%
1년 성능:
-69.00%
1일 변동 폭
$2.44
$2.7553
1주일 범위
$2.14
$2.7553
52주 변동 폭
$1.15
$8.24
Humacyte Inc Stock (HUMA) Company Profile
명칭
Humacyte Inc
전화
919-313-9633
주소
2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM
HUMA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HUMA
Humacyte Inc
|
2.48 | 342.81M | 0 | -110.78M | -75.59M | -1.07 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Humacyte Inc Stock (HUMA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-14 | 재개 | H.C. Wainwright | Buy |
| 2024-12-20 | 재확인 | H.C. Wainwright | Buy |
| 2023-12-11 | 개시 | H.C. Wainwright | Buy |
| 2023-08-14 | 업그레이드 | Piper Sandler | Underweight → Neutral |
| 2023-06-22 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-05-16 | 다운그레이드 | Piper Sandler | Overweight → Underweight |
| 2021-10-29 | 개시 | Cowen | Outperform |
| 2021-09-24 | 개시 | Oppenheimer | Outperform |
| 2021-09-22 | 개시 | BTIG Research | Buy |
| 2021-09-16 | 개시 | Piper Sandler | Overweight |
모두보기
Humacyte Inc 주식(HUMA)의 최신 뉴스
Is Humacyte Inc. forming a double bottomBottom Formation Alert - mustnews.co.kr
Humacyte HUMA Q2 2025 Earnings Preview Upside Potential Driven by Product Innovations - AInvest
Humacyte to Present Second Quarter Financial Results and Provide Corporate Update on August 11, 2025 - The Manila Times
Humacyte, Inc. (HUMA) Stock Dips While Market Gains: Key Facts - Yahoo Finance
What are Humacyte Inc. Equity Warrant company’s key revenue driversMassive stock growth - Jammu Links News
Humacyte, Inc. (HUMA) Stock Declines While Market Improves: Some Information for Investors - MSN
How does Humacyte Inc. Equity Warrant compare to its industry peersSuperior profit margins - Jammu Links News
Why is Humacyte Inc. stock attracting strong analyst attentionExceptional gains - Jammu Links News
What are Humacyte Inc. company’s key revenue driversAccess powerful market insights for free - Jammu Links News
What makes Humacyte Inc. stock price move sharplyUnlock powerful market trend analysis - Jammu Links News
How does Humacyte Inc. compare to its industry peersUnlock powerful market insights for success - Jammu Links News
What institutional investors are buying Humacyte Inc. stockFree Daily Trading Room Entry - Jammu Links News
Why is Humacyte Inc. Equity Warrant stock attracting strong analyst attentionMaximize gains with timely market signals - Jammu Links News
Should I hold or sell Humacyte Inc. Equity Warrant stock in 2025High-velocity capital appreciation - Jammu Links News
Is Humacyte Inc. a growth stock or a value stockDiscover the next big stock winners - Jammu Links News
Is Humacyte Inc. stock overvalued or undervaluedCapitalize on emerging investment opportunities - Jammu Links News
What are the latest earnings results for Humacyte Inc. Equity WarrantAchieve consistent returns with proven methods - jammulinksnews.com
What drives Humacyte Inc. Equity Warrant stock priceInvest confidently with proven investment plans - Jammu Links News
Should I hold or sell Humacyte Inc. stock in 2025Discover hidden gems in the stock market - Jammu Links News
Does Humacyte Inc. Equity Warrant stock perform well during market downturnsPhenomenal capital appreciation - Jammu Links News
How many analysts rate Humacyte Inc. as a “Buy”Capitalize on momentum-driven stocks - Jammu Links News
Published on: 2025-08-03 10:43:46 - Jammu Links News
How volatile is Humacyte Inc. stock compared to the marketInvest smarter with expert stock recommendations - Jammu Links News
What catalysts could drive Humacyte Inc. Equity Warrant stock higher in 2025Get professional advice for market timing - Jammu Links News
What is Humacyte Inc. Equity Warrant company’s growth strategyRapid return acceleration - Jammu Links News
When is Humacyte Inc. Equity Warrant stock expected to show significant growthHigh-octane financial growth - Jammu Links News
Does Humacyte Inc. stock perform well during market downturnsFree Real-Time Stock Data - Jammu Links News
What are analysts’ price targets for Humacyte Inc. in the next 12 monthsPhenomenal investment performance - Jammu Links News
What is the dividend policy of Humacyte Inc. stockBuild a winning portfolio with smart picks - Jammu Links News
Is Humacyte Inc. Equity Warrant a growth stock or a value stockExceptional market performance - Jammu Links News
Humacyte, Inc. (HUMA) Suffers a Larger Drop Than the General Market: Key Insights - MSN
Measuring Humacyte Inc.’s beta against major indicesAI Powered High Return Stock Calls Dominate Watchlists - metal.it
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Humacyte, Inc. (HUMA) Shareholders - ACCESS Newswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of January 17, 2025 in Humacyte, Inc. LawsuitHUMA - ACCESS Newswire
Humacyte, Inc. (NASDAQ:HUMA): Is Breakeven Near? - Yahoo Finance
Is Humacyte Inc. Equity Warrant in Accumulation Phase NowWealth Building Stock Market Ideas Based on Momentum - metal.it
What institutional investors are buying Humacyte Inc. Equity Warrant stockStock Market Entry Points To Watch Now - jammulinksnews.com
When is Humacyte Inc. stock expected to show significant growthAchieve rapid capital gains with smart investing - jammulinksnews.com
How strong is Humacyte Inc. Equity Warrant company’s balance sheetAchieve rapid portfolio appreciation today - jammulinksnews.com
What markets is Humacyte Inc. expanding into Is WTRG stock a good long term investment optionMassive portfolio appreciation - jammulinksnews.com
Humacyte Inc (HUMA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):